FIELD: medicine. SUBSTANCE: method involves analyzing endogenous substances like metalloproteinase or its precursor in body fluids like blood and urine to detect significant increase in endogenous substances concentration after chronic rejection process begins after kidney transplantation has taken place. EFFECT: enhanced effectiveness of method. 10 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| APPLYING 15-DEOXYSPERGUALINE FOR TREATMENT OF HYPER-REACTIVE INFLAMMATORY AND AUTOIMMUNE DISEASES | 2000 |
|
RU2255732C2 |
| DIAGNOSTIC METHOD FOR RENAL ALLOGRAFT REJECTION | 2007 |
|
RU2348932C1 |
| METHOD FOR PRODUCING REGULATORY DENDRITIC CELLS | 2011 |
|
RU2597976C2 |
| PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF DISEASES CAUSED BY IL-6 FORMATION | 1995 |
|
RU2147442C1 |
| METHOD FOR PREDICTION OF REMOTE RESULT OF KIDNEY TRANSPLANTATION | 2024 |
|
RU2841552C1 |
| METHOD OF PREPARING OPTICALLY ACTIVE ESTERS OF ERYTHRO-3-AMINO-2- HYDROXYBUTYRIC ACIDS AND CORRESPONDING ACIDS | 1997 |
|
RU2169138C2 |
| [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINE-2-YLUREA DERIVATIVE AND ITS APPLICATION | 2004 |
|
RU2348636C2 |
| PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2095061C1 |
| CHRONIC REJECTION INHIBITOR | 2008 |
|
RU2450829C2 |
| DERIVATIVES OF PHENANTHRIDINIUM SHOWING ANTITUMOR ACTIVITY, METHOD OF INHIBITION OF CANCER CELLS GROWTH | 1997 |
|
RU2183626C2 |
